Family Medicine · Essexville, MI
NPI
1720075229
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
700 Borton Ave
Essexville, MI, 48732
Phone (989) 894-2926
Medicare paid, 2024
$18K
330 services
Medicare patients, 2024
129
Average age 77
Drug cost, 2024
$697K
9,104 prescriptions
Company payments, 2024
$179
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert K Hafford was code 99214 (office e&m - established), 83 times for 62 patients. In total Robert K Hafford billed 330 services in 34 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 83 | 62 | $59.26 | $4,919 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 34 | 34 | $121.76 | $4,140 |
| 99238 Hospital Discharge Management | Facility | 17 | 15 | $61.00 | $1,037 |
| 99213 Office E&M - Established | Office | 13 | 13 | $29.54 | $384 |
| 99221 Hospital E&M - Initial | Facility | 12 | 11 | $62.90 | $755 |
By year: 2022 $81K for 1,315 services; 2023 $74K for 1,170 services; 2024 $18K for 330 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 30 | 21 | $3.41 | $102 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert K Hafford prescribed most often to Medicare patients was Simvastatin, with 455 prescriptions and refills. In total Robert K Hafford wrote 9,104 Medicare prescriptions that cost $697K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Simvastatin Generic | 455 | 1,243 | 154 | $4,298 |
| Levothyroxine Sodium Generic | 435 | 1,050 | 125 | $5,086 |
| Amlodipine Besylate Generic | 373 | 970 | 116 | $3,366 |
| Atorvastatin Calcium Generic | 368 | 913 | 112 | $4,923 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 262 | 729 | 93 | $3,017 |
| Lisinopril Generic | 231 | 624 | 73 | $2,098 |
| Metformin Hcl Generic | 190 | 463 | 58 | $1,458 |
| Furosemide Generic | 178 | 406 | 57 | $1,438 |
| Carvedilol Generic | 160 | 402 | 54 | $2,389 |
| Gabapentin Generic | 155 | 272 | 44 | $2,625 |
| Lorazepam Generic | 153 | 208 | 46 | $1,311 |
| Omeprazole Generic | 153 | 395 | 56 | $1,784 |
| Tamsulosin Hcl Generic | 151 | 389 | 52 | $3,285 |
| Metoprolol Tartrate Generic | 143 | 366 | 42 | $1,029 |
| Potassium Chloride Generic | 142 | 266 | 37 | $5,242 |
Brand drugs: 1,020 claims; generic drugs: 8,017 claims; opioid claims: 200.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Robert K Hafford $179 ($179 in general payments such as food, travel and fees) from 9 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $34.91.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $34.91 |
| Novo Nordisk Inc NVO | 2 | $31.29 |
| Biogen, Inc. BIIB | 1 | $19.41 |
| Lundbeck LLC | 1 | $17.75 |
| Pfizer Inc. PFE | 1 | $16.9 |
| Lilly USA, LLC LLY | 1 | $16.53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $14.55 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $13.81 |
| GlaxoSmithKline, LLC. GSK | 1 | $13.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.